Obinutuzumab Side Effects: Comprehensive 2025 Guide for Patients and Professionals
Introduction Obinutuzumab, marketed as Gazyva in the United States and Gazyvaro in Europe, represents a major advancement in targeted cancer therapy. It’s a humanized monoclonal antibody designed to recognize and attack the CD20 antigen present on B lymphocytes. This mechanism makes it highly effective in treating Chronic Lymphocytic Leukemia (CLL) and Follicular Lymphoma (FL)—two common …